SCHEMBL27475477

SCHEMBL27475477

Brc1cnc(Nc2ccccc2)nc1-c1cnc2ccccn12

nearest known ligand 0.55

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
IRAK4 Q9NWZ3 1/20 0.55
CDK2 P24941 12/20 0.53
IGF1R P08069 7/20 0.53
PKM P14618 2/20 0.52
CDK7 P50613 3/20 0.46
CDK9 P50750 3/20 0.46
HDAC3 O15379 2/20 0.46
HDAC1 Q13547 2/20 0.46
HDAC6 Q9UBN7 2/20 0.46
CDK1 P06493 4/20 0.46
KCNH2 Q12809 2/20 0.46
CDK8 P49336 1/20 0.46
CDK19 Q9BWU1 1/20 0.44
ALK Q9UM73 1/20 0.44
PTGS2 P35354 1/20 0.43
CDK4 P11802 2/20 0.43
CCNE1 P24864 2/20 0.43
CCNB1 P14635 1/20 0.43
GSK3B P49841 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27475476 0.88 CDK2 (0.71) CDK2IGF1RCDK7CDK9HDAC3
SCHEMBL3548956 0.80 IGF1R (0.45) IRAK4CDK2IGF1RPKMHDAC3
SCHEMBL27474684 0.78 PKM (0.51) IRAK4CDK2IGF1RPKM
SCHEMBL3313332 0.78 FLT3 (0.46) IRAK4CDK2IGF1RPKMCDK7
SCHEMBL3313903 0.78 IGF1R (0.61) CDK2IGF1RKCNH2
SCHEMBL17943211 0.77 CDK2 (0.77) IRAK4CDK2IGF1RPKMCDK1
SCHEMBL23245965 0.76 CDK2 (0.48) IRAK4CDK2IGF1RPKMCDK7
SCHEMBL29884067 0.76 CDK2 (0.48) IRAK4CDK2IGF1RPKMCDK7
SCHEMBL6593868 0.76 IGF1R (0.52) CDK2IGF1RCDK1CDK19ALK
SCHEMBL701008 0.75 GSK3B (0.57) IRAK4CDK2IGF1RCDK7CDK9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-100415744-C 2-arylamino-pyrimidines for the treatment of GSK3-related disorders ASTRAZENECA AB (SE) 2008-09-03 CN disclosed
CN-1823064-A 2-arylamino-pyrimidines for the treatment of GSK 3-related disorders ASTRAZENECA AB (SE) 2006-08-23 CN disclosed
CN-1174981-C Imidazo [1, 2-A ] pyridine and pyrazolo [2, 3-A ] pyridine derivatives 2004-11-10 CN disclosed